We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Meningococcal Vaccine Could Protect Against 91% of Targeted Bacterial Strains

News   Nov 23, 2017 | Original story from the American Society for Microbiology

 
Meningococcal Vaccine Could Protect Against 91% of Targeted Bacterial Strains
 
 
 

RELATED ARTICLES

Novel Cellular Entry Factor for Viral Vectors Used in Gene Therapy

News

Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types--the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles--that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.

READ MORE

Vaccine for African Swine Fever Virus Shows Promise

News

Government and academic investigators have developed a vaccine against African swine fever that appears to be far more effective than previously developed vaccines.

READ MORE

No Snake, No Problem – Scientists Produce Venom in a Dish

News

A new study published in the journal Cell outlines researchers' development of reptile organoids; specifically, organoids of the venom glands of the Cape coral snake. What's more, these organoids are capable of producing venom in vitro.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE